Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
9,783,925
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1,772,756
-
Shares change
-
+1,772,756
-
Total reported value, excl. options
-
$12,191,000
-
Value change
-
+$12,191,000
-
Number of buys
-
11
-
Price
-
$6.88
Significant Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q3 2021
11 filings reported holding INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share as of Q3 2021.
IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,772,756 shares
of 9,783,925 outstanding shares and own 18.12% of the company stock.
Largest 10 shareholders include Capital World Investors (800,000 shares), Nantahala Capital Management, LLC (375,000 shares), B. Riley Financial, Inc. (257,378 shares), VANGUARD GROUP INC (113,100 shares), Voss Capital, LLC (80,727 shares), Tudor Investment Corp Et Al (63,287 shares), Rock Creek Group, LP (42,279 shares), MILLENNIUM MANAGEMENT LLC (25,340 shares), BlackRock Inc. (9,311 shares), and UBS Group AG (3,435 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.